Esomeprazole but Not Pantoprazole is Associated with Lower Plasma Concentrations of Clopidogrel's Active Metabolite

Angiolillo DJ , Gibson CM , Cheng S . Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of Clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther 2011; 89:65–74.

US Food and Drug Administration safety alert for human medicinal products Clopidogrel (marketed as Plavix) and omeprazole (marketed as Prilosec)–drug interaction. http://www.fda.gov/Safety/MedWatch/Safetylnformation/SafetyAlertsforHumanMedicalProducts/ucm190848.htm (accessed 2010 Jan 16).

Taubert D , Kastrati A , Harlfinger S . Pharmacokinetics of Clopidogrel after administration of a high loading dose. Thromb Haemost 2004; 92:311–6.

Bhatt DL , Cryer BL , Contant CF . et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010; 363:1909–17.

Hulot JS , Collet JP , Silvain J . Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. J Am Coll Cardiol 2010; 56:134–43.

Guard M , Arnaud B , Cornily JC . Influence of omeprazole on the antiplatelet action of Clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study. J Am Coll Cardiol 2008; 51:256–60.

Sibbing D , Morath T , Stegherr J . Impact of proton pump inhibitors on the antiplatelet effects of Clopidogrel. Thromb Haemost 2009; 101:714–9.